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Abstract
Background: Hypertension is the leading cardiovascular risk factor globally as well as in Malaysia. This study aimed
to estimate the prevalence, awareness, treatment, control and the socio demographic determinants of hypertension
among Malaysian adults.
Method: The analytic sample consisted of 11,288 adults aged ≥ 30 years recruited at baseline in 2007–2011 from
the REDISCOVER Study which is an ongoing, prospective cohort study involving 18 urban and 22 rural communities
in Malaysia. Socio-demographics, anti-hypertensive treatment details and an average of at least two blood pressure
measurements were obtained.
Results: The age-adjusted prevalence was 42.0 % (CI: 40.9–43.2) and was higher in men [43.5 % (CI: 41.2–45.0)]
than women [41.0 % (CI: 39.8–42.3)]. Participants from rural areas (APR: 1.12, CI: 1.04–1.20); aged at least 40–49 years
(APR: 1.86, CI: 1.62–2.14); who were overweight (APR: 1.24, CI: 1.15–1.34) and obese (APR: 1.54, CI: 1.43–1.6) were
more likely to have hypertension. The Indigenous ethnic group was less likely to be aware (APR: 0.81, CI: 0.69–0.92)
and to be on treatment (APR: 0.66, CI: 0.55–0.79). Those in rural areas were less likely to have their hypertension
controlled (APR: 0.61, CI: 0.49–0.75). On the other hand, control was more likely in females (APR: 1.25, CI: 1.01–1.54)
and Indigenous group (APR: 1.64, CI: 1.19–2.25).
Conclusion: Hypertension is common in the Malaysian adults. The control of hypertension has increased over the
years but is still quite low. Public health measures, as well as individual interventions in primary care are crucial to
reduce their risk of developing complications.
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Background
Hypertension is the number one cardiovascular risk fac-
tor and the leading cause of mortality worldwide [1].
Malaysia, like other developing countries is experiencing
an upsurge in cardiovascular morbidity and mortality
[2]. The emergence of cardiovascular disease as a leading
cause of death in Malaysia runs parallel with the rapid
economic growth and associated socio-demographic
change that has occurred over the past few decades.
Thus, achieving blood pressure (BP) control and pre-
vention of cardiovascular morbidity and mortality is
vital and should be strived for, as many effective and
inexpensive BP treatments options are now available.
Data on prevalence, awareness, treatment and control
in various communities are necessary for monitoring
and developing new strategies for hypertension control.
A few reports have documented the national prevalence,
awareness and treatment rates in Malaysia [2–5]. A
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national health morbidity survey (NHMS) conducted in
2011 among adults aged ≥18 years reported that the overall
prevalence of hypertension was 32.7 % and the treatment
rate of those who were aware was 78.4 % [4]. Another study
conducted a decade ago reported that the overall preva-
lence, treatment and control among individuals aged
≥15 years were 27.8 %, 32.4 % and 8.6 % respectively [3].
Although local data on the prevalence, awareness, treat-
ment and control of hypertension were available, data on
variation between urban and rural settings and body mass
index (BMI) are still lacking. Such information is vital to
guide the allocation of resources towards developing strat-
egies for better detection and control of hypertension in
Malaysia. Therefore, this study aimed to evaluate the preva-
lence, treatment, awareness and control of hypertension in
Malaysia and the association with socio-demographic fac-
tors including urban–rural and BMI variations.
Methods
Sampling methods: The REDISCOVER Study is an on-
going prospective cohort study involving Malaysian adults
aged ≥ 30 years from 18 urban and 22 rural communities
from the states of Selangor, Negeri Sembilan, Pahang, Ke-
lantan, Sarawak and Sabah, and the Federal Territory of
Kuala Lumpur. Participants were selected in a four-stage
sampling process: selecting the states and then the ‘com-
munities’, followed by households within them and finally
individuals within the households. The 5 states were
chosen to ensure adequate representation of the major
ethnic groups in Malaysia. A standardized method of re-
cruitment was adopted. All household members aged ≥
30 years were invited to attend screening sessions in local
community centres. Approximately, 20 000 invitations
were sent out. A response rate of 60–70 % was recorded
at each site. At the screening sites, participants were given
information leaflet about the study and were screened
for eligibility. Written informed consent was obtained
from those who were eligible and willing to participate.
The baseline data was collected from 2007 to 2011.
The study duration is 15 years and data collection is
repeated every three years. The cross-sectional analytic
sample presented in this paper consisted of 11,288
participants who were recruited at baseline. A detailed
description of the design and methodology of this study
has been published elsewhere [6]. The institutional ethics
committee approved the study protocol.
Study procedures: All interviewers and investigators
were trained regarding the study procedures prior to the
conduct of the study in order to standardize the data
collection and to minimize variability during data collec-
tion. Standardized, pre-tested, interviewer-based question-
naires were used to collect information regarding age,
gender, ethnic group, educational level, smoking status,
and known history and treatment of hypertension.
The blood pressure was measured at least twice at five
minutes apart on the right arm supported at heart level,
using Omron automatic digital blood pressure monitor
(Omron HEM-757). Participants were advised not to
smoke, exercise or eat in the last 30 min, not to climb
stairs in the last 15–30 min, and were made to rest for
at least five minutes before the measurements were
taken. The average of the two BP readings was used for
analysis. If the measurements differ by 5 mmHg of either
systolic or diastolic readings, subsequent measurements
were taken at 5–10 min apart. The process was repeated
until two BP values, which did not differ by more than
5 mmHg of either systolic or diastolic readings, were ob-
tained. The average of these two BP readings was used
as the BP value for that particular subject.
Definitions of socio-demographic factors: Urban and
rural areas were defined according to the Malaysian
Population and Housing Census 2000 [7]. Gazetted areas
with a combined population of 10,000 or more were
identified as urban areas and all the other areas with a
population of less than 10,000 were classified as rural.
Ethnic groups were categorized as Malays, Chinese, Indians
and Indigenous. Kadazan-Dusun, Bajau, Murut and several
other ethnic minorities who live in East Malaysia repre-
sented the Indigenous group. Education attainment levels
were classified into four categories as ‘no formal education’,
‘primary’, ‘secondary’ and ‘tertiary’. Participants who had
never been to school to get any form of education were
categorised into ‘no formal education’, while ‘primary’
education level represented those with at least 7 years
of schooling at primary school. ‘Secondary’ education
level represented those with at least 5 years of schooling at
secondary school, whereas ‘tertiary’ education level repre-
sented those who attended colleges or universities. Current
smokers were defined as participants who were currently
smoking cigarettes or had smoked cigarettes within the past
five years. Ex- smokers were those who had stopped smok-
ing for more than five years and non-smokers were those
who had never smoked. BMI was classified according to
the Malaysia Guideline on the Management of Obesity,
2004 [8]. Underweight was defined as BMI < 18.5 kg/m2,
normal range as BMI of 18.5–22.9 kg/m2, overweight as
BMI of 23–27.4 kg/m2 and obesity as BMI ≥ 27.5 kg/m2.
Definition of hypertension, awareness, treatment and
control: Hypertension was defined according to the
Malaysia Guideline on the Management of Hypertension,
3rd Edition, 2008. “Hypertension” was considered to be
present if: (1) the average systolic BP ≥ 140 mmHg and/or
average diastolic BP ≥ 90 mmHg; (2) or the participants
reported a history of hypertension; (3) or participants
reported taking anti-hypertensive medications in the
past two weeks. “Awareness of hypertension” was defined
as self-report of any previous diagnosis of hypertension by
a healthcare professional among those with hypertension.
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“Treatment of hypertension” was defined as self-reported
use of antihypertensive medications among those with
hypertension. “Control among hypertensive participants”
was defined as having a BP < 140/90 mmHg among those
with hypertension.
Data analysis
Our study population was described in terms of its
socio-demographic characteristics using simple descriptive
statistics. Data were presented as percentages for categor-
ical variables and numerical variables were described with
mean (± Standard Deviation [SD]). The overall prevalence
of hypertension, awareness, treatment and control were
described for the total study population with 95 % confi-
dence interval (CI). The prevalence of hypertension was
also age standardized using World Health Organisation
(WHO) world population for people aged 30 years and
above. The modified Poisson regression model with robust
variance was used to estimate the crude and adjusted
prevalence ratio [9, 10] in this study. To identify independ-
ent factors associated of being hypertensive, aware, treated
and controlled; location, gender, age, ethnicity, education
attainment, smoking status and BMI were controlled for
each other using the modified Poisson regression model.
The crude prevalence ratios (CPR) were compared to ad-
justed prevalence ratios (APR) and their 95 % CI. A two-
sided P-value of <0.05 was considered to be statistically
significant. All analyses were performed using STATA
software version 11.1 with (StataCorp.TX).
Results
Characteristics of the respondents
A total of 11 288 eligible adults participated in this study.
Table 1 shows the socio-demographic characteristics of
the participants by locality, age, gender, ethnicity, educa-
tion attainment, smoking status and BMI. The mean age
was 53.02 (SD ±10.9) years. There were more participants
from urban areas (51.9 %) and females (56.2 %). Majority
of the participants were Malays (72.5 %), followed by Indi-
genous group (13.8 %), Chinese (10.8 %) and Indians
(2.9 %). In terms of education attainment, 38.4 % of the
participants had secondary education level and majority
had never smoked cigarette (75.6 %). The proportions of
participants who were overweight and obese were 38.7 %
and 34.3 %, respectively.
Prevalence of hypertension, awareness, treatment and
control
Table 2 shows the overall prevalence of hypertension,
awareness, treatment, and control by locality, gender,
ethnicity, education attainment, smoking status and
BMI. The overall prevalence of hypertension in our sam-
ple was 47.9 % (CI: 47.0–49.0). The age-adjusted preva-
lence was 42.0 % (CI: 40.9–43.2) and was higher in men
[43.5 % (CI: 41.2–45.0)] than women [41.0 % (CI: 39.8–
42.3)]. Out of those who have hypertension, 53.2 % (CI:
51.9–54.5) were aware, 38.2 % (CI: 36.9–39.5) were on
treatment, and 15.9 % (CI: 14.9–16.9) had their BP con-
trolled. Out of those who were aware, 72.3 % (CI: 70.6–
73.9) received treatment and 30.3 % (CI: 28.7–32.0) had
their BP controlled. Out of those who were treated,
30.7 % (CI: 28.7–32.7) achieved BP control.
In terms of locality, there was a significantly higher
prevalence of hypertension in the rural than in urban
areas (51.2 % vs. 44.9 %, p < 0.001). However, there was a
significantly lower prevalence of treatment (34.7 % vs.
42.0 %, p < 0.001) and control (13.1 % vs. 18.9 %, p < 0.001)
Table 1 Demographic characteristics
Demographic characteristics
All subjects (n, %) 11,288 (100)
















Indigenous group 1559 (13.8)
Education attainment (na, %)




Smoking status (na, %)
Non smoker 8014 (75.6)
Current smoker 1367 (12.9)
Ex-smoker 1224 (11.5)





na is not equal to 11 288 due to missing values
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N=5409 N=2837 N=2022 N= 2022 N=861 N=861 N=621
Prevalence (95% Confidence Interval)
Overall 47.9 (47.0- 49.0) 53.2 (51.9-54.5) 38.2 (36.9 -39.5) 72.3 (70.6 – 73.9) 15.9 (14.9-16.9) 30.3 (28.7 – 32.0) 30.7 (28.7 -32.7)
Location
Urban 44.9 (43.6 – 46.2) 54.1 (52.2 – 56.1) 42.0 (40.1 – 43.9) 78.4 (76.2 – 80.6) 18.9 (17.4 – 20.4) 35.6 (33.1 – 38.1) 36.5 (33.7 – 39.4)
Rural 51.2 (49.8 – 52.4) 52.3 (50.5 – 54.2) 34.7 (32.9 – 36.4) 66.4 (63.9 – 68.8) 13.1 (11.8 – 14.4) 25.2 (22.9 – 27.5) 24.2 (21.4 – 26.9)
P-value < 0.001* 0.190 <0.001* <0.001* <0.001* < 0.001* <0.001*
Gender
Male 50.9 (49.5 – 52.3) 49.5 (47.6 – 51.5) 35.9 (34.0 – 37.8) 73.0 (70.5 – 75.5) 14.2 (12.8 – 15.5) 29.0 (26.5 – 31.6) 30.4 (27.3 – 33.4)
Female 45.6 (44.3 – 46.8) 56.4 (54.6 -58.2) 40.2 (38.4 – 42.0) 71.7 (69.5 – 73.9) 17.4 (16.1 – 18.8) 31.3 (29.1 – 33.6) 31.0 (28.3 – 33.7)
P-value <0.001* <0.001* 0.001* 0.428 0.001 * 0.185 0.757
Age (years)
30-39 19.1 (16.9 – 21.3) 35.3 (29.2 – 41.4) 19.6 (14.5 – 24.7) 55.4 (44.7 – 66.2) 13.1 (8.8 – 17.5) 37.3 (26.9 – 47.8) 37.0 (22.8 – 51.1)
40-49 35.7 (34.0 – 37.3) 48.0 (45.1 – 50.9) 29.5 (26.9 – 32.1) 61.8 (57.8 – 65.9) 17.1 (14.9 – 19.2) 36.0 (32.0 – 40.0) 33.9 (28.9 – 38.9)
50-59 51.6 (49.9 – 53.2) 53.2 (50.9 – 55.5) 39.1 (36.9 – 41.4) 74.1 (71.3 – 76.8) 16.2 (14.5 – 17.9) 30.7 (27.8 – 33.6) 31.9 (28.5 – 35.3)
≥ 60 68.2 (66.6 – 69.8) 58.1 (56.1 – 60.3) 44.4 (42.3 – 46.6) 76.8 (74.4 – 79.2) 15.4 (13.8 – 16.9) 26.9 (24.5 – 29.5) 28.3 (25.3 – 31.2)
P-value < 0.001* < 0.001* < 0.001* <0.001* 0.373 0.001* 0.137
Ethnic Group
Malays 48.3 (47.2 – 49.3) 55.8 (54.2 -57.3) 40.4 (38.9 – 42.0) 73.0 (71.2 – 74.9) 16.1 (15.0 -17.3) 29.3 (27.4 – 31.3) 29.4 (27.2 -31.7)
Chinese 47.5 (44.7 – 50.3) 52.3 (48.2 – 56.4) 43.6 (39.5 – 47.7) 83.4 (79.2 – 87.7) 16.3 (13.3 – 19.3) 31.8 (26.4 – 37.1) 32.4 (26.5 – 38.2)
Indians 44.9 (39.6 – 50.4) 51.4 (43.2 – 59.5) 40.4 (32.4 – 48.4) 78.7 (69.3 – 88.0) 21.8 (15.1 – 28.5) 42.7 (31.4 – 53.9) 45.8 (32.9 – 58.6)
Indigenous 47.0 (44.5 – 49.5) 40.4 (36.8 – 44.0) 21.6 (18.6 – 24.6) 53.6 (47.9 – 59.3) 13.2 (10.8 – 15.7) 33.2 (27.8 – 38.6) 35.3 (27.7 – 42.8)




57.3 (54.9 – 59.8) 51.2 (48.0 – 54.5) 33.6 (30.4 – 36.7) 65.6 (61.3 -70.0) 14.3 (11.8 – 16.3) 27.5 (23.4 – 31.5) 29.0 (23.9 – 34.1)
Primary 58.7 (56.9 – 60.6) 58.2 (55.8 – 60.6) 42.7 (40.3 – 45.1) 73.7 (70.9 – 76.6) 14.7 (13.0 – 16.4) 25.3 (22.5 – 28.1) 25.9 (22.6 – 29.1)
Secondary 45.1 (43.5 – 46.6) 50.7 (48.3 – 53.0) 37.1 (34.8 – 39.4) 73.8 (70.9 – 76.7) 16.2 (14.5 – 17.9) 32.1 (29.1 – 35.2) 30.8 (27.3 – 34.4)
Tertiary 39.1 (36.9 – 41.2) 52.1 (48.6 – 55.7) 38.0 (34.5 – 41.4) 73.0 (68.6 -77.4) 21.2 (18.3 -24.1) 40.8 (36.0 – 45.6) 42.5 (36.8 – 48.1)
P-value <0.001* <0.001* <0.001* 0.007* <0.001* < 0.001* <0.001*
Smoking status
Never smoke 49.5 (48.4 – 50.6) 53.5 (52.0 – 55.1) 39.2 (37.6 – 40.7) 73.7 (71.8 – 75.6) 16.0 (14.8 – 17.1) 29.9 (28.0 – 31.9) 30.1 (27.8 – 32.4)
Current smoker 42.3 (39.7 – 45.0) 48.0 (43.9 – 52.1) 30.1 (26.4 – 33.9) 63.1 (57.4 - 68.9) 14.0 (11.2 – 16.8) 29.2 (23.9 – 34.6) 28.9 (22.1 – 35.7)
Ex-smoker 58.3 (55.5 – 61.0) 55.3 (51.6 – 58.9) 39.2 (35.6 – 42.8) 71.1 (66.6 -75.6) 17.7 (14.9 – 20.5) 32.1 (27.4 – 36.7) 34.2 (28.6 – 39.8)
P-value <0.001* 0.022* <0.001* <0.001* 0.199 0.656 0.356
Body Mass Index
Normal 39.3 (37.4 – 41.2) 46.7 (43.5 – 49.8) 30.2 (27.3 – 33.1) 65.1 (60.6 -69.5) 15.0 (12.8 – 17.3) 32.7 (28.3 – 37.0) 32.2 (26.8 – 37.6)
Underweight 31.4 (26.8 – 36.0) 37.0 (28.3 – 45.7) 20.2 (12.9 – 27.4) 54.4 (39.7 -69.4) 11.4 (5.7 – 17.0) 31.8 (17.9 – 45.7) 29.2 (10.6 – 47.8)
Overweight 48.6 (47.1 – 50.1) 50.4 (48.3 – 52.7) 36.1 (34.0 – 38.2) 72.1 (69.3 – 74.9) 15.8 (14.2 – 17.4) 31.8 (28.9 – 34.7) 31.6 (28.2 – 35.0)
Obese 60.6 (59.0 – 62.2) 59.5 (57.4 – 61.6) 44.6 (42.6 – 46.8) 75.4 (73.0 – 77.7) 16.4 (14.8 – 17.9) 27.8 (25.4 – 30.2) 29.1 (26.2 – 31.9)
P-value < 0.001* < 0.001* < 0.001* < 0.001* 0.426 0.108 0.627
* significant at p < 0.05
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among hypertensive participants in the rural compared to
urban areas, respectively. Among those who were aware,
there was also a significantly lower prevalence of treatment
(66.4 % vs. 78.4 %, p < 0.001) and control (25.2 % vs. 35.6 %,
p < 0.001) in the rural compared to urban areas. Out of
those who were treated, there was also a significantly lower
prevalence of control (24.2 % vs. 36.5 %, p < 0.001) in the
rural compared to urban areas.
Males had a significantly higher prevalence of hyper-
tension compared to females, (50.9 % vs. 45.6 %, p <
0.001). However, a significantly lower prevalence of
awareness (49.5 % vs. 56.4 %, p < 0.001), treatment
(35.9 % vs. 40.2 %, p = 0.001) and control (14.2 %
vs.17.4 %, p = 0.001) were observed in males compared
to females among hypertensive participants. With
regards to age, participants aged ≥ 60 years had the high-
est prevalence of hypertension (68.2 %), awareness
(58.1 %) and treatment (44.4 %) compared to the other
age groups.
There was no significant difference of prevalence of
hypertension among the ethnic groups. Malays had the
highest prevalence of awareness (55.8 %) while Chinese
had the highest prevalence of treatment (43.6 %) com-
pared to other ethnic groups. In contrast, the Indigenous
group had the lowest prevalence of awareness (40.4 %)
and treatment (21.6 %) compared to other ethnic groups.
These trends were significant.
Participants with primary education attainment had
the highest prevalence of hypertension (58.7 %), aware-
ness (58.2 %) and treatment (42.7 %) compared to those
in other education levels. Meanwhile, those with tertiary
education level had the highest prevalence of control
(21.2 %) compared to those in other education levels.
These trends were significant. Ex- smokers had the high-
est prevalence of hypertension (58.3 %). In contrast,
current smokers had the lowest prevalence of awareness
(48.0 %) and treatment (30.1 %) compared to non-
smokers or ex-smokers. Obese participants had the
highest prevalence of hypertension (60.6 %), awareness
(59.5 %) and treatment (44.6 %) compared to those in
other BMI categories.
Socio-demographic factors associated with hyperten-
sion, awareness, treatment and control
Table 3 shows factors associated with hypertension,
awareness, treatment and control among treated hyper-
tensive participants. In a modified Poisson regression
model that controlled for location, gender, age, ethnicity,
education level, smoking status and BMI, the independ-
ent factors associated with hypertension were residing in
the rural areas, female, age, Chinese, tertiary education,
current smoker and all BMI categories. Meanwhile, the
factors associated with awareness among the hypertensive
participants were female, age, Indigenous groups and
being obese. Factors associated with treatment among
hypertensive participants were female, age, Indigenous
groups and being overweight or obese. With regards to
factors associated with control among treated participants,
residing in the rural areas, female and Indian were identi-
fied as the independent factors.
Discussion
The REDISCOVER Study provided evidence that nearly
one in two (overall prevalence = 47.9 %; age-adjusted
prevalence = 42.0 %) Malaysians over 30 years of age
were hypertensive and its treatment and control were
still inadequate. Using the same age cut off ≥ 30 years
old, this study showed a rising overall prevalence of
hypertension compared to the NHMS 2011 (43.5 %) [4],
NHMS III 2006 (42.6 %) [11] and NHMS II 1996
(32.9 %) [5]. In addition, when comparing Malaysia
to the other South East Asian countries, Malaysia
had the highest prevalence of hypertension among
adults ≥ 18 years (32.7 %) according to NHMS 2011
[4] compared to Singapore (26.6 %), Indonesia (23.%)
and Thailand (20.5 %) [12]. A similar rising trend is
also observed in the prevalence of other associated
cardiovascular risk factors among the Malaysian
population e.g. obesity and dyslipidaemia [6]. Urbanization
phenomenon, sedentary lifestyle, high consumption of salt
and fatty food may have contributed to the rising preva-
lence of hypertension and the associated cardiovascular
risk factors in Malaysia [13].
With regards to the awareness rate in Malaysian
adults ≥ 30 years of age, REDISCOVER showed a higher
awareness (53.2 %) compared to NHMS 2011 (42.5 %)
[4], NHMS III (35.8 %) [11] and NHMS II (33.0 %) [5].
Nevertheless, a much higher rate of awareness was ob-
served in a developed country like the USA (82.9 % in
men and 80.3 % in women ≥ 30 years) [14] and also
amongst the rural community in Thailand (64.9 %) [15].
Despite an improved awareness, the treatment rate ob-
served in this study was lower when compared to
Thailand (38.2 vs. 42.6 %) [15] and has not changed
much compared to an earlier local study (32.4 %) [3].
However, the treatment rate was comparable to coun-
tries like China (34.1 %) [16] and Turkey (37.7 %) [17].
Among hypertensive participants in this study who were
aware of their hypertension status, the treatment rate
(72.3 %) was comparable to the finding in NHMS 2011
(78.4 %) [4].
An improved overall control rate was observed in this
study (15.9 %) when compared to NHMS III (8.2 %) [11]
and NHMS II (6 %) [5]. Similarly, this study showed an
improvement in the control rate amongst those on treat-
ment (30.7 %) compared to NHMS III and II which
showed a stagnant rate of 26.0 % [5, 11]. The improve-
ments in the awareness, treatment and control rates over
the last decades may have been attributed to the various
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Table 3 Factors associated with prevalence of hypertension, awareness, treatment and control among treated hypertensive participants
Risk Factors Hypertension Awareness among hypertensive participants Treatment among hypertensive participants Control among treated participants
CPR (CI) APR† (CI) CPR (CI) APR† (CI) CPR (CI) APR† (CI) CPR (CI) APR† (CI)
Location
Urban 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Rural 1.14 (1.08–1.20)** 1.12 (1.04–1.20)* 0.97 (0.9–1.04) 1.03 (0.94–1.13) 0.83 (0.76–0.90)** 0.95 (0.85–1.06) 0.66 (0.56–0.78)** 0.61 (0.49–0.75)**
Gender
Male 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Female 0.90 (0.85–0.95)** 0.88 (0.83–0.94)** 1.14 (1.06–1.23)* 1.19 (1.08–1.31)** 1.12 (1.02–1.22)* 1.13 (1.01–1.26)* 1.02 (0.87–1.2) 1.25 (1.01–1.54)*
Age (years)
30–39 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
40–49 1.86 (1.62–2.14)** 1.71 (1.48–1.98)** 1.36 (1.08–1.71)* 1.30 (1.03–1.65)* 1.51 (1.11–2.05)* 1.50 (1.09–2.07)* 0.92 (0.55–1.53) 0.92 (0.54–1.55)
50–59 2.70 (2.35–3.09)** 2.37 (2.06–2.74)** 1.51 (1.2–1.89)** 1.45 (1.15–1.83)* 2.00 (1.48–2.69)** 1.98 (1.45–2.70)** 0.86 (0.53–1.41) 0.85 (0.51–1.42)
≥60 3.56 (3.12–4.08)** 3.17 (2.74–3.67)** 1.65 (1.32–2.06)** 1.63 (1.29–2.06)** 2.27 (1.69–3.05)** 2.36 (1.73–3.24)** 0.77 (0.47–1.25) 0.77 (0.46–1.31)
Ethnicity
Malay 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Chinese 0.99 (0.9–1.08) 1.12 (1.01–1.24)* 0.94 (0.83–1.06) 1.01 (0.88–1.16) 1.08 (0.94–1.24) 1.13 (0.97–1.32) 1.10 (0.87–1.40) 0.90 (0.69–1.18)
Indian 0.93 (0.79–1.1) 1.04 (0.87–1.24) 0.92 (0.73–1.16) 0.95 (0.74–1.22) 1.00 (0.77–1.30) 1.00 (0.76–1.33) 1.56 (1.06–2.29)* 1.35 (0.89–2.04)
Indigenous groups 0.97 (0.9–1.05) 1.04 (0.95–1.14) 0.72 (0.64–0.82)** 0.80 (0.69–0.92)* 0.53 (0.45–0.63)** 0.66 (0.55–0.79)** 1.20 (0.91–1.59) 1.64 (1.19–2.25)*
Education attainment
No formal education 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Primary 1.03 (0.94–1.11) 1.00 (0.92–1.1) 1.14 (1.02–1.27)* 1.09 (0.96–1.22) 1.27 (1.11–1.46)* 1.15 (1.00–1.33) 0.89 (0.69–1.15) 1.03 (0.78–1.35)
Secondary 0.79 (0.73–0.85)** 0.94 (0.85–1.03) 0.99 (0.88–1.11) 0.99 (0.86–1.12) 1.11 (0.96–1.27) 1.05 (0.9–1.23) 1.06 (0.83–1.37) 1.03 (0.77–1.38)
Tertiary 0.68 (0.62–0.75)** 0.86 (0.76–0.96)* 1.02 (0.89–1.16) 1.05 (0.89–1.23) 1.13 (0.96–1.33) 1.07 (0.89–1.3) 1.46 (1.11–1.93)* 1.30 (0.94–1.81)
Smoking status
Never smoke 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Current smoker 0.86 (0.78–0.93)** 0.81 (0.73–0.89)** 0.90 (0.79–1.02) 0.99 (0.86–1.14) 0.77 (0.66–0.90)* 0.84 (0.7–1.00) 0.96 (0.72–1.28) 1.11 (0.79–1.55)
Ex-smoker 1.18 (1.09–1.27)** 1.00 (0.91–1.09) 1.03 (0.93–1.15) 1.12 (0.98–1.26) 1.00 (0.88–1.14) 1.04 (0.9–1.21) 1.13 (0.91–1.41) 1.28 (0.99–1.67)
Body Mass Index
Normal 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Underweight 0.80 (0.66–0.96)* 0.72 (0.59–0.89)* 0.79 (0.58–1.08) 0.77 (0.56–1.08) 0.67 (0.44–1.01) 0.69 (0.45–1.07) 0.91 (0.42–1.95) 1.31 (0.6–2.87)
Overweight 1.24 (1.15–1.34)** 1.31 (1.2–1.42)** 1.08 (0.97–1.21) 1.10 (0.98–1.24) 1.20 (1.04–1.37)* 1.19 (1.03–1.38)* 0.98 (0.77–1.25) 0.95 (0.74–1.23)
Obese 1.54 (1.43–1.66)** 1.71 (1.58–1.86)** 1.28 (1.15–1.42)** 1.30 (1.16–1.46)** 1.48 (1.3–1.69)** 1.51 (1.31–1.74)** 0.90 (0.72–1.14) 0.88 (0.68–1.13)
†Modified Poisson regression model
CPR: Crude prevalence ratio, APR: Adjusted prevalence ratio, CI: 95 % confidence interval














public health and primary care measures mooted by the
Health Ministry. These include continuous enhancement
of the public primary care services, as well as improve-
ments in the availability of antihypertensive agents in
health clinics where majority of the hypertensive individ-
uals are managed. Nevertheless, efforts to heighten public
awareness, treatment and control should be continued
and further enhanced.
Globally, the prevalence of hypertension in the urban
adult populations were between 15–35 % but was found
to be lower in the rural Asian populations [18]. Interest-
ingly, in comparing the urban and rural populace in this
study, there was a higher prevalence of hypertension in
the rural compared to the urban population (51.2 % vs.
44.9 %). Rural population was found to be more likely to
have hypertension (APR: 1.12, CI: 1.04–1.20). This is in
contrast to studies in Africa [19, 20] and India [21]
where higher prevalence of hypertension were observed
in their urban populations. The higher prevalence of
hypertension in the rural population in this study could
be explained by lifestyle factors such as physical inactiv-
ity, excess dietary intake of sodium and fat as well as
obesity which have spread from urban to rural areas at
an alarming rate [13]. A strong correlation between
urbanization and prevalence of hypertension was also
evidenced in India, where a sharp increase in per capita
net domestic product, growth production and human
development indexed correlated positively with the
hypertension increase in rural areas [22]. A significantly
lower control rates in the rural areas were observed in
this study which were similar to other studies in China
and Thailand [23, 24]. Rural population was less likely to
achieve control (APR 0.61; CI: 0.49–0.75) compared to
their urban counterparts. Poorer BP control in the rural
participants may be due to lack of knowledge on hyper-
tension and disparity in healthcare services available in
the rural compared to urban areas. The geographical
condition of East Malaysia that is still preserved with the
tropical rain forest and rivers as the main transportation
method remains a challenge in establishing good access
to healthcare. The other possibility is the use of com-
plementary and alternative medicines as part of self-
management and this was found to be prevalent in
rural areas [25]. This study highlights the need to put
more efforts to reduce the prevalence and increase the
control of hypertension in the rural areas of Malaysia.
In evaluating gender differences, a higher age adjusted
prevalence of hypertension was observed in males than
in females. However, females had a significantly higher
prevalence of awareness, treatment and control which
were consistent with other studies [15, 26]. In the regres-
sion analyses, females were less likely to have hypertension
(APR 0.88; CI: 0.83–0.94) but they were more likely to be
aware (APR 1.19; CI: 1.08–1.31), to be treated (APR 1.13;
CI: 1.01–1.26) and to achieve BP control once treated
(APR 1.25; CI: 1.01–1.54) when compared to males.
This data suggests the importance of raising hypertension
awareness as well as controlling hypertension in men. A
recent review highlighted the importance of promoting
and improving men’s health in the country due to a higher
prevalence of cardiovascular risk factors and an increasing
cancer related death among men [27]. Barriers to health
seeking behaviour among men include lack of time to
adopt healthy lifestyle, men’s enjoyment to be among
fellow smokers and men’s perception of invulnerability
to illness [28]. More studies are needed to identify effective
strategies to improve men’s health seeking behavior and
efforts to improve men’s health should be in place.
Published evidences have shown that older age was as-
sociated with a higher prevalence, awareness and treat-
ment of hypertension [29–31] which were consistent with
findings from REDISCOVER. Participants aged ≥ 60 years
old were found to be three times more likely to have
hypertension (APR 3.17; CI 2.74–3.67), almost twice more
likely to be aware (APR 1.63; CI: 1.29–2.06) and twice
more likely to be on treatment (APR 2.36; CI 1.73–3.24)
compared to participants aged 30–39 years in the study. It
was postulated that older people who are at higher cardio-
vascular risk have better awareness and hence receive
treatment more than younger individuals. It is concerning
to note that younger individuals were less aware of their
hypertension status and were less likely to be on antihy-
pertensive treatment. Hence, it is important to educate
younger individuals to have regular health screening and
to seek treatment early in order to minimize cardiovascu-
lar complications.
There was no significant difference in prevalence of
hypertension among the ethnic groups in this study.
Earlier studies conducted locally noted that all ethnic
groups were found to have uniformly high prevalence of
hypertension [2, 3]. REDISCOVER also found that the
Indigenous groups who resided in the remote areas were
less likely to be aware (APR 0.8; CI: 0.69–0.92) and to be
on treatment (APR 0.66; CI: 0.55–0.79) for hypertension
compared to the Malays.
This study shows that participants with primary edu-
cation level had the highest prevalence of hypertension,
awareness and treatment, while those with tertiary edu-
cation level had the highest prevalence of control. Those
with tertiary education level were also found to be less
likely to have hypertension (APR 0.86; CI: 0.76–0.96).
This trend was also found in another study [32]. Those
with lower education attainment may be leading a less
healthy lifestyle to explain the higher prevalence of
hypertension, and may have a lack of knowledge on the
importance of good hypertension control. This finding
underlines the needs to deliver better patient education
targeting those with lower education level.
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Ex-smokers had a significantly higher prevalence of
hypertension than non-smokers or current-smokers. This
finding was supported by other study which found that
the prevalence of hypertension was higher in former
smokers than non-smokers and the risk was associated
with higher body mass and higher prevalence of obesity in
ex-smokers [33]. However, further regression analyses
found that current smokers were found to be less likely
(APR 0.81; CI: 0.73–0.89) to have hypertension compared
to non-smokers. Further studies are needed to understand
the effects of smoking status and hypertension. Nonethe-
less, smoking was identified as a risk factor for develop-
ment of hypertension [34].
Overweight and obese participants in this study were
found to have the highest prevalence of hypertension
compared to those in the other BMI categories. Partici-
pants who were overweight (APR 1.31; CI: 1.20–1.42)
and obese (APR 1.71; CI: 1.58–1.86) were found to be
more likely to have hypertension, which support the
postulation that obesity are risk factors for hypertension
[16, 32, 35]. It was reported that Asian populations are
more inclined to obesity with increased insulin resist-
ance compared to their Western counterparts [36].
Hence, with increasing globalization together with haz-
ardous behaviour which are highly prevalent in Malaysia
e.g. smoking [37], high fat intake and low physical activ-
ity [13, 38]; concerted efforts need to be taken to reduce
these modifiable risk factors in our population.
REDISCOVER gave insight on the current magnitude
of hypertension burden in the Malaysian population.
Higher hypertension prevalence would translate into
higher number of individuals with future cardiovascular
diseases and events; leading to increased utilization of
healthcare services, escalating health care costs, increased
premature deaths, reduced productivity and increased
economic burden [1, 39]. Public health measures, as well
as individual interventions in primary care are crucial to
reduce this rising epidemic. Public health measures should
include multi-sectorial collaborations involving relevant
stakeholders in the community. At the primary care level,
individual patients aged ≥ 30 years old should be routinely
screened for hypertension and its associated cardiovascu-
lar risk factors at regular intervals and at opportunistic
times. Special attention should be given to groups most
affected and those who were least aware, treated and
controlled. These include the rural population, male
participants, Indigenous group, younger, overweight and
obese individuals. Programs may incorporate intervention
to improve the knowledge, attitude and behaviours of pa-
tients and health care professionals in order to diagnose
hypertension early and improve adherence to treatment to
achieve better control and prevent complications.
This study has several limitations. First, comparisons
in the prevalence of hypertension, awareness, treatment
and control rates with other countries may be hindered
by the different methodologies and criteria used between
studies. Second, information bias may have been present
with respect to both recall diagnosis of hypertension and
treatment. However, proper training of all manpower in-
volved in conducting the survey and its procedures min-
imized potential bias. Third, two measurements of BP
on a single visit were used to diagnose hypertension in
this study as opposed to the recommendation by the
Malaysian CPG of Management of Hypertension, 3rd
edition, 2008, which recommended BP measurements
on at least 2 separate visits for diagnosis [40]. However,
similar method was used to diagnose hypertension in
the other national surveys and several other studies due
to the difficulties to measure BP on 2 separate visits in
large population surveys [3, 41]. Fourth, Malays were
over represented, while Chinese and Indian populations
were under represented in this study as Malaysia’s ethnic
population comprises 53.3 % Malays, 26.0 % Chinese,
7.7 % Indians and the remaining 13 % are of other ethnic
groups [7]. Our study population also had more females
and older individuals than the Malaysian population.
This may be due to the fact that males and younger par-
ticipants were working when screenings were conducted,
or females were more health conscious and therefore,
were more likely to attend health screening programmes.
Hence, interpretation of the result should be done with
caution. Nevertheless, the large sample size of this study
population should counter balance any possible bias in
the sampling.
Conclusion
In conclusion, REDISCOVER highlights an alarming
situation as almost half of Malaysian adults aged ≥ 30 years
have hypertension and of those, only half were aware of
their hypertension status, less than 40 % were on treatment
and only a third of those were controlled. Comprehensive
intervention strategies that target the general population, as
well as focus on improving awareness, treatment and
control among rural population, men, younger individuals,
Indigenous groups, overweight and obese individuals must
be put in place. Findings from this study emphasize the
urgency to stem the rising tide of hypertension prevalence
and the almost inevitable emerging epidemic of cardiovas-
cular diseases in Malaysia. Public health measures, as well
as individual interventions in primary care are crucial to
reduce their risk of developing complications.
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